Liver Diseases  >>  Licartin (Iodine-131-labeled metuximab)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Licartin (Iodine-131-labeled metuximab) / Chinese Government
NCT00829465: Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma

Completed
4
400
RoW
Licartin, TACE and Licartin, Transcatheter arterial chemoembolization
Eastern Hepatobiliary Surgery Hospital
Unresectable Hepatocellular Carcinoma
12/09
12/10

Download Options